Early ART reduces anal cancer: study
Findings show that sustained undetectable viral loads could reduce the risk by half
Early initiation of antiretroviral therapy (ART) in patients newly diagnosed with HIV can cut the prevalence of anal high-risk HPV infection by one-third, a study shows.
The findings, from a systematic review and meta-analysis, also suggest that those on ART with sustained undetectable viral loads could almost halve their risk of anal cancer, the researchers say.
The international team, led by the Catalan Institute of Oncology in Barcelona, Spain, assessed data from 122 studies with 417,000
